Anadys Forms Collaboration With Gilead

Anadys Pharmaceuticals, Inc. and Gilead Sciences, Inc. have entered into a collaboration to discover novel antiviral compounds. As part of the collaboration agreement, Anadys will design, configure and run uHTS-ATLAS screens against a key viral target selected by Gilead. This agreement leverages Anadys’ powerful ability to screen for small molecules that bind to proteins that Read more about Anadys Forms Collaboration With Gilead[…]

Cerylid, Anadys Sign Anti-infective Collaboration

Cerylid Biosciences Limited and Anadys Pharmaceuticals, Inc. have announced a strategic partnership for the discovery of novel anti-infective compounds. This partnership will utilize Anadys’ uHTS-ATLAS technology to screen Cerylid’s world leading collection of natural products against key Anadys targets. Under the terms of the collaboration, Anadys will gain access to Cerylid’s extensive library of unique Read more about Cerylid, Anadys Sign Anti-infective Collaboration[…]

Anadys And Sequoia Sciences Announce Drug Discovery Collaboration

Anadys Pharmaceuticals, Inc. and Sequoia Sciences, Inc. have entered into a drug discovery collaboration to identify novel anti-infectives. This partnership will harness Sequoia’s unique library of compounds isolated from natural products using the fully integrated drug discovery capabilities of Anadys. Under the terms of the agreement, Anadys will deploy its proprietary screening technologies uHTS-ATLAS and Read more about Anadys And Sequoia Sciences Announce Drug Discovery Collaboration[…]